Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.

Biomarkers and asthma management: analysis and potential applications.

Richards LB, Neerincx AH, van Bragt JJMH, Sterk PJ, Bel EHD, Maitland-van der Zee AH.

Curr Opin Allergy Clin Immunol. 2018 Jan 31. doi: 10.1097/ACI.0000000000000426. [Epub ahead of print]

PMID:
29389730
2.

Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.

de Vries R, Dagelet YWF, Spoor P, Snoey E, Jak PMC, Brinkman P, Dijkers E, Bootsma SK, Elskamp F, de Jongh FHC, Haarman EG, In 't Veen JCCM, Maitland-van der Zee AH, Sterk PJ.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701817. doi: 10.1183/13993003.01817-2017. Print 2018 Jan.

PMID:
29326334
3.

Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis.

Ragia G, Karantza IM, Kelli-Kota E, Kolovou V, Kolovou G, Konstantinides S, Maltezos E, Tavridou A, Tziakas D, Maitland-van der Zee AH, Manolopoulos VG.

Drug Metab Pers Ther. 2017 Dec 20;32(4):183-190. doi: 10.1515/dmpt-2017-0034.

PMID:
29252193
4.
5.

Treatment response heterogeneity in asthma: the role of genetic variation.

Vijverberg SJH, Farzan N, Slob EMA, Neerincx AH, Maitland-van der Zee AH.

Expert Rev Respir Med. 2018 Jan;12(1):55-65. doi: 10.1080/17476348.2018.1403318. Epub 2017 Nov 21.

PMID:
29115880
6.

Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.

Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJM, Appel IM, Tamminga RYJ, de Boer A, Maitland-van der Zee AH.

J Thromb Haemost. 2018 Jan;16(1):116-124. doi: 10.1111/jth.13897. Epub 2017 Nov 23.

PMID:
29108090
7.

Early-life antibiotic exposure increases the risk of developing allergic symptoms later in life: A meta-analysis.

Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Lang JE, Garssen J, Kraneveld A, Maitland-van der Zee AH.

Allergy. 2017 Nov 6. doi: 10.1111/all.13332. [Epub ahead of print] Review.

PMID:
29105784
8.

Breathomics from exhaled volatile organic compounds in pediatric asthma.

Neerincx AH, Vijverberg SJH, Bos LDJ, Brinkman P, van der Schee MP, de Vries R, Sterk PJ, Maitland-van der Zee AH.

Pediatr Pulmonol. 2017 Dec;52(12):1616-1627. doi: 10.1002/ppul.23785. Epub 2017 Oct 30. Review.

PMID:
29082668
9.

The association between a genetic risk score for allergy and the risk of developing allergies in childhood-Results of the WHISTLER cohort.

Arabkhazaeli A, Ahmadizar F, Leusink M, Arets HGM, Raaijmakers JAM, Uiterwaal CSPM, van der Ent CK, Maitland-van der Zee AH, Vijverberg SJH.

Pediatr Allergy Immunol. 2018 Feb;29(1):72-77. doi: 10.1111/pai.12824. Epub 2017 Nov 22.

PMID:
29047167
10.

A common missense variant of LILRB5 is associated with statin intolerance and myalgia.

K Siddiqui M, Maroteau C, Veluchamy A, Tornio A, Tavendale R, Carr F, Abelega NU, Carr D, Bloch K, Hallberg P, Yue QY, Pearson ER, Colhoun HM, Morris AD, Dow E, George J, Pirmohamed M, Ridker PM, Doney ASF, Alfirevic A, Wadelius M, Maitland-van der Zee AH, Chasman DI, Palmer CNA; PREDICTION-ADR Consortium.

Eur Heart J. 2017 Dec 21;38(48):3569-3575. doi: 10.1093/eurheartj/ehx467.

PMID:
29020356
11.

CKM Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia.

Siddiqui MK, Veluchamy A, Maroteau C, Tavendale R, Carr F, Pearson E, Colhoun H, Morris AD, George J, Doney A, Pirmohamed M, Alfirevic A, Wadelius M, Maitland van der Zee AH, Ridker PM, Chasman DI, Palmer CNA; PREDICTION-ADR Consortium.

Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001737. doi: 10.1161/CIRCGENETICS.117.001737.

PMID:
28790154
12.

Breastfeeding is associated with a decreased risk of childhood asthma exacerbations later in life.

Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Garssen J, Kraneveld AD, Maitland-van der Zee AH.

Pediatr Allergy Immunol. 2017 Nov;28(7):649-654. doi: 10.1111/pai.12760. Epub 2017 Sep 6.

PMID:
28755494
13.

Early health technology assessments in pharmacogenomics: a case example in cardiovascular drugs.

Geenen JW, Baranova EV, Asselbergs FW, de Boer A, Vreman RA, Palmer CN, Maitland-van der Zee AH, Hövels AM.

Pharmacogenomics. 2017 Aug;18(12):1143-1153. doi: 10.2217/pgs-2017-0063. Epub 2017 Jul 26.

PMID:
28745583
14.

Asthma treatment patterns in Dutch children using medication dispensing data.

Arabkhazaeli A, Vijverberg SJH, van der Ent CK, Raaijmakers JAM, Maitland-van der Zee AH.

Pediatr Allergy Immunol. 2017 Sep;28(6):606-608. doi: 10.1111/pai.12751. Epub 2017 Jul 27. No abstract available.

PMID:
28661552
15.

Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium.

Farzan N, Vijverberg SJ, Andiappan AK, Arianto L, Berce V, Blanca-López N, Bisgaard H, Bønnelykke K, Burchard EG, Campo P, Canino G, Carleton B, Celedón JC, Chew FT, Chiang WC, Cloutier MM, Daley D, Den Dekker HT, Dijk FN, Duijts L, Flores C, Forno E, Hawcutt DB, Hernandez-Pacheco N, de Jongste JC, Kabesch M, Koppelman GH, Manolopoulos VG, Melén E, Mukhopadhyay S, Nilsson S, Palmer CN, Pino-Yanes M, Pirmohamed M, Potočnik U, Raaijmakers JA, Repnik K, Schieck M, Sio YY, Smyth RL, Szalai C, Tantisira KG, Turner S, van der Schee MP, Verhamme KM, Maitland-van der Zee AH.

Pharmacogenomics. 2017 Jul;18(10):931-943. doi: 10.2217/pgs-2017-0035. Epub 2017 Jun 22.

PMID:
28639505
16.

Atopic dermatitis characteristics and medication-use patterns in school-age children with AD and asthma symptoms.

van der Lee M, Arabkhazaeli A, van Erp FC, Raaijmakers JA, van der Ent CK, Bruijnzeel-Koomen CAFM, de Bruin-Weller MS, Vijverberg SJH, Maitland-van der Zee AH.

Clin Exp Dermatol. 2017 Jul;42(5):503-508. doi: 10.1111/ced.13111. Epub 2017 Jun 6.

PMID:
28585727
17.

Early life antibiotic use and the risk of asthma and asthma exacerbations in children.

Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Turner S, Devereux G, Arabkhazaeli A, Soares P, Mukhopadhyay S, Garssen J, Palmer CNA, de Jongste JC, Jaddoe VWV, Duijts L, van Meel ER, Kraneveld AD, Maitland-van der Zee AH.

Pediatr Allergy Immunol. 2017 Aug;28(5):430-437. doi: 10.1111/pai.12725. Epub 2017 Jun 8.

PMID:
28423467
18.

Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study.

Alharbi FF, Souverein PC, de Groot MC, Maitland-van der Zee AH, de Boer A, Klungel OH.

J Hum Hypertens. 2017 Aug;31(8):537-544. doi: 10.1038/jhh.2017.1. Epub 2017 Mar 23.

PMID:
28332511
19.

The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial.

Vijverberg SJ, Pijnenburg MW, Hövels AM, Koppelman GH, Maitland-van der Zee AH.

Pharmacogenomics. 2017 Mar;18(4):393-401. doi: 10.2217/pgs-2016-0174. Epub 2017 Feb 22. Review.

PMID:
28244806
20.

Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts.

Oshagbemi OA, Burden AM, Braeken DCW, Henskens Y, Wouters EFM, Driessen JHM, Maitland-van der Zee AH, de Vries F, Franssen FME.

Am J Respir Crit Care Med. 2017 May 15;195(10):1402-1404. doi: 10.1164/rccm.201701-0009LE. No abstract available.

PMID:
28165763

Supplemental Content

Loading ...
Support Center